Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Sprint Interval Training

Research Leaders

6 sponsors active, led by University of Wyoming

Related Conditions

Often studied with 11 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (1)
Phase 2 (1)
Phase 4 (1)

Trial Status

Unknown4
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (5)

Showing 5 of 5 trials
NCT03666416Not ApplicableUnknown

Acute Effects of Exercise in College Students With ADHD

NCT03935646Phase 2Unknown

Acute Effects of Stimulant Medication in College Students With ADHD

NCT01592175CompletedPrimary

Magnetoencephalography (MEG), Attention and Conscience

NCT02928796UnknownPrimary

Attentional Capacity and Clinician Performance

NCT01459146Phase 4Unknown

Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren in Kassena-Nankana, Ghana

Showing all 5 trials

Research Network

Common Treatments

  • Sprint Interval Training1
  • Adderall Ir 10mg1
  • Artemetherlumefantrine Plus Praziquantel Plus Albendazole1
  • Cognitive Stimulus1
  • Albendazole Plus Praziquantel1

Active Sponsors

  • University of Wyoming2
  • Navrongo Health Research Centre, Ghana1
  • University College Cork1
  • Institut National de la Santé Et de la Recherche Médicale, France1
  • University of Ulster1

Top Investigators

Related Conditions

  • Working Memory2
  • Attention Deficit Hyperactivity Disorder2
  • Stimulant Use1
  • Schistosomiasis1
  • Helminthiasis1

Activity Timeline